{"version":"1.0","provider_name":"Clinical Diagnostics","provider_url":"https:\/\/clinical.r-biopharm.com\/de\/","author_name":"cmunz","author_url":"https:\/\/clinical.r-biopharm.com\/de\/news\/author\/cmunz\/","title":"Adalimumab-Monitoring verbessert Therapieerfolg (de) - Clinical Diagnostics","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"nINbSa6UvT\"><a href=\"https:\/\/clinical.r-biopharm.com\/de\/news\/adalimumab-monitoring-verbessert-therapieerfolg\/\">Adalimumab-Monitoring verbessert Therapieerfolg<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/clinical.r-biopharm.com\/de\/news\/adalimumab-monitoring-verbessert-therapieerfolg\/embed\/#?secret=nINbSa6UvT\" width=\"600\" height=\"338\" title=\"&#8222;Adalimumab-Monitoring verbessert Therapieerfolg&#8220; &#8211; Clinical Diagnostics\" data-secret=\"nINbSa6UvT\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/clinical.r-biopharm.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2015\/09\/TNFalpha-blocker-drugmonitoring-1.jpg","thumbnail_width":690,"thumbnail_height":252,"description":"[vc_row][vc_column][vc_column_text css=&#8220;.vc_custom_1557387156755{margin-bottom: 0px !important;}&#8220;]Das Medikament Adalimumab wird bei verschiedenen entz\u00fcndlichen Erkrankungen sehr erfolgreich eingesetzt. Doch bei einem Teil der Patienten verliert das Medikament mit der Zeit seine Wirkung. Wir erkl\u00e4ren, warum das so ist und wie Medikamenten-Monitoring zu einem langfristigen Therapieerfolg beitragen kann."}